Ligand Pharma(LGND)
$301.71-7.08 (-2.29%)
LGND
Ligand Pharma Revenue
$301.71
At close:-7.08 (-2.29%)
Want to see LGND full AI Analyst Report?
Ligand Pharma (LGND) Revenue
860 Followers
Ligand Pharma Revenue
Ligand Pharma had a revenue of 78.75M in the quarter ending Sep 30, 2026, with 23.63%. This bring the company's revenue in the last twelve months to 253.83M, Decreased 12.64%. In the fiscal year ending Dec 31, 2025, Ligand Pharma had annual revenue of 268.09M with 60.40% growth.
- Revenue (ttm)
- 253.83M
- Revenue Growth
- 1.03%
- P/S Ratio
- 23.04
- Revenue/Employee
- $5,703,979
- Employees
- 47
- Market Cap
- $6.18B
Revenue Chart
Ligand Pharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 268.09M | 100.95M | 60.40% |
| Dec 31, 2024 | 167.13M | 35.82M | 27.28% |
| Dec 31, 2023 | 131.31M | -64.93M | -33.09% |
| Dec 31, 2022 | 196.25M | -45.30M | -18.75% |
| Dec 31, 2021 | 241.54M | 77.98M | 47.68% |
| Dec 31, 2020 | 163.56M | 43.28M | 35.98% |
| Dec 31, 2019 | 120.28M | -131.17M | -52.17% |
| Dec 31, 2018 | 251.45M | 110.35M | 78.21% |
| Dec 31, 2017 | 141.10M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

